Nuestra Contribución Científica

  • Hypofractionated whole breast irradiation after IORT treatment: evaluation of acute toxicity and cosmesis. Clin Transl Oncol. 2020 May 22. doi: 10.1007/s12094-020-02400-z. 
  • Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients. Transl Cancer Res 2020;9(Suppl 1):S197-S206
  • Adjuvant radiotherapy for low-risk early breast cancer in elderly women: evidence from randomized trials. Transl Cancer Res 2020;9(Suppl 1):S207-S216
  • Accelerated partial breast irradiation with interstitial multicatheter brachytherapy after breast-conserving surgery for low-risk early breast cancer. Breast. 2020 Aug;52:45-49
  • Complications and local relapse after intraoperative low-voltage X-ray radiotherapy in breast cancer.Ann Surg Treat Res. 2020 Jun;98(6):299-306. 
  • Inverse radiotherapy planning in reconstructive surgery for breast cancer. Int J Surg. 2019 Mar;63:77-82. 
  • Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study. Clin Transl Oncol. 2020 Jan;22(1):151-157. 
  • Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment. Clin Transl Radiat Oncol. 2020 Apr 25;23:27-29. 
  • Whole-lung Low Dose Irradiation for SARS-Cov2 Induced Pneumonia in the Geriatric Population: An Old Effective Treatment for a New Disease? Recommendation of the International Geriatric Radiotherapy Group.Aging Dis. 2020 May 9;11(3):489-493. doi: 10.14336/AD.2020.0506. eCollection 2020 May.
  • Older Cancer Patients during the COVID-19 Epidemic: Practice Proposal of the International Geriatric Radiotherapy Group. Cancers (Basel). 2020 May 19;12(5):1287. doi: 10.3390/cancers12051287.
  • Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ Eur Urol. 2020 May 20:S0302-2838(20)30192-5. 
  • EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees. Eur Urol. 2020 Feb;77(2):223-250. 
  • EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees .Ann Oncol. 2019 Nov 1;30(11):1697-1727. 
  • Recommended ESTRO Core Curriculum for Radiation Oncology/Radiotherapy 4th edition.Radiother Oncol. 2019 Dec;141:1-4. 
  • Feasibility of a deep hyperthermia and radiotherapy programme for advanced tumors: first Spanish experience. Clin Transl Oncol. 2019 Dec;21(12):1771-1775. 
  • Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review. Int J Mol Sci. 2019 May 2;20(9):2173. 
  • Are there enough radiation oncologists to lead the new Spanish radiotherapy? Clin Transl Oncol. 2019 Dec;21(12):1663-1672
  • Morphologic Features on MR Imaging Classify Multifocal Glioblastomas in Different Prognostic Groups. AJNR Am J Neuroradiol. 2019 Apr;40(4):634-640
  • LXR Signaling Regulates Macrophage Survival and Inflammation in Response to Ionizing Radiation. Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):913-923. 
  • Challenges Facing Radiation Oncologists in The Management of Older Cancer Patients: Consensus of The International Geriatric Radiotherapy Group. Cancers (Basel). 2019 Mar 16;11(3):371
  • Correction to: Morphological MRI-based features provide pretreatment survival prediction in glioblastoma. Eur Radiol. 2019 May;29(5):2729. 
  • Nanoparticles as a promising method to enhance the abscopal effect in the era of new targeted therapies.Rep Pract Oncol Radiother. 2019 Jan-Feb;24(1):86-91. 
  • Definition of Episodic Dyspnea in Cancer Patients: A Delphi-Based Consensus among Spanish Experts: The INSPIRA Study.J Palliat Med. 2019 Apr;22(4):413-419. 
  • Morphological MRI-based features provide pretreatment survival prediction in glioblastoma. Eur Radiol. 2019 Apr;29(4):1968-1977. doi: 10.1007/s00330-018-5758-7. Epub 2018 Oct 15.
  • Immune mechanisms mediating abscopal effects in radioimmunotherapy. Pharmacol Ther. 2019 ;196:195-203. 
  • Evaluation of the applicability of BI-RADS® MRI for the interpretation of contrast-enhanced digital mammography. Radiologia. 2019 Jun 28. pii: S0033-8338(19)30065-7. 
  • Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesions. Radiol Med. 2019 Oct;124(10):1006-1017. 
  • Adult-onset Alexander disease with a heterozygous D128N GFAP mutation: a pathological study. Histol Histopathol. 2019 Sep;34(9):1073-188. 
  • Multiple vertebral fractures as the first manifestation of systemic mastocytosis. Osteoporos Int. 2019 May;30(5):1121-1124. doi: 10.1007/s00198-019-04897-9. 
  • Intraoperative radiotherapy with the Intrabeam® device for the treatment of resectable pancreatic adenocarcinoma. Cir Esp. 2018 Oct;96(8):482-487. doi: 10.1016/j.ciresp.2018.04.014. Epub 2018 Jul 7

25-06-2020

Compartir:

Artículos Relacionados